MaxCyte (MXCT) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free MXCT Stock Alerts $4.54 -0.17 (-3.61%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media MaxCyte Stock Price Performance5 Day Performance-1.69%1 Month Performance+16.25%3 Month Performance-0.43%6 Month Performance+25.34%Year-To-Date Performance-1.06%1 Year Performance+21.57% Receive MXCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him MXCT Stock Chart for Tuesday, May, 14, 2024 MXCT Chart by TradingView MaxCyte Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$4.74$4.71-0.63%$4.82$4.68194,079 shs$492.38 million05/10/2024$4.73$4.74+0.21%$4.79$4.60358,493 shs$495.54 million05/09/2024$4.64$4.73+1.94%$4.79$4.46896,063 shs$494.49 million05/08/2024$3.93$4.64+18.07%$5.13$3.942.82 million shs$485.08 million05/07/2024$3.91$3.93+0.51%$3.95$3.79315,268 shs$410.86 million05/06/2024$3.77$3.91+3.71%$3.92$3.78370,999 shs$408.75 million Get the Latest News and Ratings for MXCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$3.83$3.77-1.57%$3.94$3.74477,677 shs$393.59 million05/02/2024$3.78$3.83+1.32%$3.85$3.62517,179 shs$399.84 million05/01/2024$3.63$3.78+4.13%$3.90$3.61651,319 shs$394.63 million04/30/2024$3.66$3.63-0.82%$3.71$3.57516,032 shs$378.97 million04/29/2024$3.71$3.66-1.35%$3.78$3.63341,756 shs$382.10 million04/26/2024$3.69$3.71+0.54%$3.74$3.59340,199 shs$387.32 million04/25/2024$3.74$3.69-1.34%$3.75$3.60429,334 shs$385.24 million04/24/2024$3.80$3.74-1.58%$3.80$3.67380,299 shs$390.46 million04/23/2024$3.96$3.80-4.04%$4.11$3.78569,042 shs$396.71 million04/22/2024$3.95$3.96+0.25%$3.97$3.87748,618 shs$413.42 million04/19/2024$3.88$3.95+1.80%$3.97$3.81534,108 shs$412.38 million04/18/2024$3.94$3.88-1.52%$3.94$3.82529,592 shs$405.06 million04/17/2024$3.99$3.94-1.25%$4.01$3.87825,008 shs$411.34 million04/16/2024$3.88$3.99+2.84%$4.01$3.82500,154 shs$416.56 million04/15/2024$4.00$3.88-3.00%$4.00$3.84279,668 shs$405.07 million04/12/2024$4.13$4.00-3.15%$4.15$4.00513,140 shs$417.60 million04/11/2024$4.09$4.13+0.98%$4.15$4.05284,871 shs$431.17 million04/10/2024$4.15$4.09-1.45%$4.18$4.08351,252 shs$427.00 million04/09/2024$4.14$4.15+0.24%$4.23$4.12269,214 shs$433.24 million04/08/2024$4.15$4.14-0.24%$4.20$4.10171,261 shs$432.22 million04/05/2024$4.12$4.15+0.73%$4.23$4.07285,152 shs$433.26 million04/04/2024$4.25$4.12-3.06%$4.27$4.10860,469 shs$428.88 million04/03/2024$4.11$4.25+3.41%$4.26$4.05608,689 shs$442.43 million04/02/2024$4.19$4.11-1.91%$4.22$4.07407,680 shs$427.85 million04/01/2024$4.19$4.19$4.21$4.05524,476 shs$436.18 million03/29/2024$4.19$4.19$4.34$4.16609,733 shs$436.17 million03/28/2024$4.32$4.19-3.01%$4.34$4.16609,632 shs$436.18 million03/27/2024$4.34$4.32-0.46%$4.50$4.22616,486 shs$449.71 million03/26/2024$4.35$4.34-0.23%$4.45$4.34417,734 shs$451.79 million03/25/2024$4.42$4.35-1.58%$4.46$4.31377,098 shs$452.84 million03/22/2024$4.51$4.42-2.00%$4.53$4.42499,561 shs$460.12 million03/21/2024$4.50$4.51+0.22%$4.61$4.44670,597 shs$469.49 million03/20/2024$4.46$4.50+0.90%$4.59$4.34485,669 shs$468.45 million03/19/2024$4.17$4.46+6.95%$4.56$4.07772,616 shs$464.27 millionAmerica could fall from this event (Ad)America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. 03/18/2024$4.31$4.17-3.25%$4.30$4.07560,885 shs$434.10 million03/15/2024$4.20$4.31+2.62%$4.39$4.15859,413 shs$448.67 million03/14/2024$4.16$4.20+0.96%$4.34$4.051.01 million shs$437.21 million03/13/2024$3.98$4.16+4.52%$4.41$3.981.10 million shs$433.06 million03/12/2024$3.97$3.98+0.25%$4.00$3.85907,197 shs$414.32 million03/11/2024$3.94$3.97+0.76%$4.06$3.94663,828 shs$413.28 million03/08/2024$4.02$3.94-1.99%$4.10$3.93475,086 shs$410.15 million03/07/2024$4.00$4.02+0.50%$4.05$3.97919,706 shs$418.48 million03/06/2024$4.10$4.00-2.44%$4.11$3.931.13 million shs$416.40 million03/05/2024$4.67$4.10-12.21%$4.63$4.03984,161 shs$426.44 million03/04/2024$4.71$4.67-0.85%$4.72$4.60284,272 shs$485.73 million03/01/2024$4.60$4.71+2.39%$4.80$4.56474,589 shs$489.89 million02/29/2024$4.58$4.60+0.44%$4.70$4.53549,078 shs$478.45 million02/28/2024$4.65$4.58-1.51%$4.67$4.57299,772 shs$476.37 million02/27/2024$4.54$4.65+2.42%$4.68$4.50327,486 shs$483.65 million02/26/2024$4.59$4.54-1.09%$4.66$4.47350,308 shs$472.21 million02/23/2024$4.51$4.59+1.77%$4.65$4.48281,814 shs$477.41 million02/22/2024$4.50$4.51+0.22%$4.57$4.47309,654 shs$469.09 million02/21/2024$4.56$4.50-1.32%$4.61$4.41543,309 shs$468.05 million02/20/2024$4.72$4.56-3.39%$4.68$4.50465,658 shs$474.29 million02/19/2024$4.72$4.72$4.84$4.64423,700 shs$490.93 million02/16/2024$4.79$4.72-1.46%$4.83$4.64423,597 shs$490.93 million02/15/2024$4.67$4.79+2.57%$4.86$4.58882,314 shs$498.21 million02/14/2024$4.75$4.67-1.68%$4.88$4.62867,063 shs$485.73 million02/13/2024$4.95$4.75-4.04%$4.87$4.71665,787 shs$494.05 million Related Companies: MeiraGTx Stock Price Chart OmniAb Stock Price Chart Absci Stock Price Chart Harvard Bioscience Stock Price Chart Inotiv Stock Price Chart Anika Therapeutics Stock Price Chart TScan Therapeutics Stock Price Chart Beauty Health Stock Price Chart Bioventus Stock Price Chart Tourmaline Bio Stock Price Chart Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MXCT) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressElon to Transform U.S. Economy? Porter & CompanyThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.